AskTheDate.com
Back to calendar

Keros Therapeutics, Inc. (KROS) Earnings

KROS reports earnings on Wednesday, November 11, 2026

earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.94
Actual EPS: $-1.45
EPS surprise: -8.21%
Company overview
Market Cap$219.7M
PriceUSD 11.08
EPS (TTM)-3.70
52-week high22.55
52-week low9.69
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees78
Buy me a coffee